These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12167346)

  • 1. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
    Paulson EJ; Fingeroth JD; Yates JL; Speck SH
    Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
    Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
    J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
    Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
    Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
    Schaefer BC; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
    Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
    J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
    Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
    J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
    Yoo L; Speck SH
    J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of latent Epstein-Barr virus promoters.
    Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
    Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    Yoshioka M; Crum MM; Sample JT
    J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
    J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
    Tierney RJ; Steven N; Young LS; Rickinson AB
    J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenotypes of latent herpesvirus genomes.
    Minarovits J
    Curr Top Microbiol Immunol; 2006; 310():61-80. PubMed ID: 16909907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
    Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
    PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
    Schaefer BC; Paulson E; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
    Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.